• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水溶性富勒烯C衍生物是流感病毒复制的有效抑制剂。

Water-Soluble Fullerene C Derivatives Are Effective Inhibitors of Influenza Virus Replication.

作者信息

Sinegubova Ekaterina O, Kraevaya Olga A, Volobueva Aleksandrina S, Zhilenkov Alexander V, Shestakov Alexander F, Baykov Sergey V, Troshin Pavel A, Zarubaev Vladimir V

机构信息

Saint Petersburg Pasteur Institute, 14 Ulitsa Mira, 197101 St. Petersburg, Russia.

Federal Research Center for Problems of Chemical Physics and Medicinal Chemistry RAS, 1 Prospekt Akademika Semenova, 142432 Chernogolovka, Russia.

出版信息

Microorganisms. 2023 Mar 7;11(3):681. doi: 10.3390/microorganisms11030681.

DOI:10.3390/microorganisms11030681
PMID:36985255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10053623/
Abstract

The influenza virus genome features a very high mutation rate leading to the rapid selection of drug-resistant strains. Due to the emergence of drug-resistant strains, there is a need for the further development of new potent antivirals against influenza with a broad activity spectrum. Thus, the search for a novel, effective broad-spectrum antiviral agent is a top priority of medical science and healthcare systems. In this paper, derivatives based on fullerenes with broad virus inhibiting activities in vitro against a panel of influenza viruses were described. The antiviral properties of water-soluble fullerene derivatives were studied. It was demonstrated that the library of compounds based on fullerenes has cytoprotective activity. Maximum virus-inhibiting activity and minimum toxicity were found with compound , containing residues of salts of 2-amino-3-cyclopropylpropanoic acid (CC > 300 µg/mL, IC = 4.73 µg/mL, SI = 64). This study represents the initial stage in a study of fullerenes as anti-influenza drugs. The results of the study lead us conclude that five leading compounds (-) have pharmacological prospects.

摘要

流感病毒基因组具有非常高的突变率,导致耐药毒株迅速出现。由于耐药毒株的出现,需要进一步开发新型强效的抗流感病毒药物,且具有广谱活性。因此,寻找一种新型、有效的广谱抗病毒药物是医学和医疗保健系统的首要任务。本文描述了基于富勒烯的衍生物,其在体外对一组流感病毒具有广泛的病毒抑制活性。研究了水溶性富勒烯衍生物的抗病毒特性。结果表明,基于富勒烯的化合物库具有细胞保护活性。化合物含有2-氨基-3-环丙基丙酸的盐残基,具有最大的病毒抑制活性和最小的毒性(CC>300μg/mL,IC=4.73μg/mL,SI=64)。本研究是富勒烯作为抗流感药物研究的初始阶段。研究结果使我们得出结论,五种主要化合物(-)具有药理学前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a5/10053623/b3c4cf71a59f/microorganisms-11-00681-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a5/10053623/d8314208023e/microorganisms-11-00681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a5/10053623/f919a24af94d/microorganisms-11-00681-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a5/10053623/c9fbab6d01ad/microorganisms-11-00681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a5/10053623/b3c4cf71a59f/microorganisms-11-00681-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a5/10053623/d8314208023e/microorganisms-11-00681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a5/10053623/f919a24af94d/microorganisms-11-00681-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a5/10053623/c9fbab6d01ad/microorganisms-11-00681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a5/10053623/b3c4cf71a59f/microorganisms-11-00681-g004.jpg

相似文献

1
Water-Soluble Fullerene C Derivatives Are Effective Inhibitors of Influenza Virus Replication.水溶性富勒烯C衍生物是流感病毒复制的有效抑制剂。
Microorganisms. 2023 Mar 7;11(3):681. doi: 10.3390/microorganisms11030681.
2
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.吡唑类化合物 BPR1P0034 具有强效和选择性的抗流感病毒活性。
J Biomed Sci. 2010 Feb 23;17(1):13. doi: 10.1186/1423-0127-17-13.
3
Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.具有抗甲型和乙型流感病毒广谱抗病毒活性的新型化合物的鉴定与表征
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.02149-19.
4
[In vitro antiviral activity of fullerene amino acid derivatives in cytomegalovirus infection].[富勒烯氨基酸衍生物在巨细胞病毒感染中的体外抗病毒活性]
Antibiot Khimioter. 2004;49(8-9):13-20.
5
Anti-influenza activity of c60 fullerene derivatives.C60 富勒烯衍生物的抗流感活性。
PLoS One. 2013 Jun 13;8(6):e66337. doi: 10.1371/journal.pone.0066337. Print 2013.
6
[Effect of fullerene C60-polyvinilpyrrolidone complexes on influenza virus reproduction].[富勒烯C60-聚乙烯吡咯烷酮复合物对流感病毒繁殖的影响]
Vopr Virusol. 2001 May-Jun;46(3):38-42.
7
Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin.靶向血凝素保守区域的强效甲型流感病毒进入抑制剂。
Biochem Pharmacol. 2017 Nov 15;144:35-51. doi: 10.1016/j.bcp.2017.07.023. Epub 2017 Aug 1.
8
Water-soluble fullerene derivatives for drug discovery.用于药物研发的水溶性富勒烯衍生物。
J Nippon Med Sch. 2012;79(4):248-54. doi: 10.1272/jnms.79.248.
9
[Development of Bio-active Fullerene Derivatives Suitable for Drug].[适用于药物的生物活性富勒烯衍生物的研发]
Yakugaku Zasshi. 2022;142(2):165-179. doi: 10.1248/yakushi.21-00188.
10
Anticoronavirus Activity of Water-Soluble Pristine C Fullerenes: In Vitro and In Silico Screenings.水溶性 Pristine C 富勒烯的抗冠状病毒活性:体外和计算机筛选。
Adv Exp Med Biol. 2021;1352:159-172. doi: 10.1007/978-3-030-85109-5_10.

引用本文的文献

1
A Regulatory-Compliant Genotoxicity Study of a Mixture of C60 and C70 Fullerenes Dissolved in Olive Oil Using the Mammalian Micronucleus Test.使用哺乳动物微核试验对溶解于橄榄油中的C60和C70富勒烯混合物进行符合法规要求的遗传毒性研究。
Nanomaterials (Basel). 2025 Jun 5;15(11):870. doi: 10.3390/nano15110870.
2
Highly aqueously stable C-polymer nanoparticles with excellent photodynamic property for potential cancer treatment.具有优异光动力性能的高度水稳定C聚合物纳米颗粒用于潜在的癌症治疗。
Smart Med. 2023 Dec 20;2(4):e20230033. doi: 10.1002/SMMD.20230033. eCollection 2023 Nov.
3
A regulatory compliant short-term oral toxicity study of soluble [60]fullerenes in rats.

本文引用的文献

1
Anti-Inflammatory and Antioxidant Effects of Liposoluble C60 at the Cellular, Molecular, and Whole-Animal Levels.脂溶性C60在细胞、分子和整体动物水平上的抗炎和抗氧化作用。
J Inflamm Res. 2023 Jan 7;16:83-93. doi: 10.2147/JIR.S386381. eCollection 2023.
2
Endohedral Gd-Containing Fullerenol: Toxicity, Antioxidant Activity, and Regulation of Reactive Oxygen Species in Cellular and Enzymatic Systems.内腔含钆富勒醇:细胞和酶系统中活性氧的毒性、抗氧化活性和调节作用。
Int J Mol Sci. 2022 May 5;23(9):5152. doi: 10.3390/ijms23095152.
3
Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.
大鼠体内可溶性[60]富勒烯的符合法规要求的短期口服毒性研究。
EXCLI J. 2024 May 15;23:772-786. doi: 10.17179/excli2024-7084. eCollection 2024.
新型1,3,4-恶二唑衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem. 2022 Mar 1;57:116647. doi: 10.1016/j.bmc.2022.116647. Epub 2022 Jan 30.
4
[Development of Bio-active Fullerene Derivatives Suitable for Drug].[适用于药物的生物活性富勒烯衍生物的研发]
Yakugaku Zasshi. 2022;142(2):165-179. doi: 10.1248/yakushi.21-00188.
5
Toxicity and Antioxidant Activity of Fullerenol C with Low Number of Oxygen Substituents.低取代数富勒醇 C 的毒性和抗氧化活性。
Int J Mol Sci. 2021 Jun 15;22(12):6382. doi: 10.3390/ijms22126382.
6
Antioxidant Potential of Aqueous Dispersions of Fullerenes C, C, and Gd@C.富勒烯 C、C 和 Gd@C 的水基分散体的抗氧化潜力。
Int J Mol Sci. 2021 May 29;22(11):5838. doi: 10.3390/ijms22115838.
7
Identification of potential descriptors of water-soluble fullerene derivatives responsible for antitumor effects on lung cancer cells via QSAR analysis.通过定量构效关系(QSAR)分析确定对肺癌细胞具有抗肿瘤作用的水溶性富勒烯衍生物的潜在描述符。
Comput Struct Biotechnol J. 2021 Jan 16;19:812-825. doi: 10.1016/j.csbj.2021.01.012. eCollection 2021.
8
Thiophene-based water-soluble fullerene derivatives as highly potent antiherpetic pharmaceuticals.基于噻吩的水溶性富勒烯衍生物作为高效抗疱疹药物。
Org Biomol Chem. 2020 Nov 4;18(42):8702-8708. doi: 10.1039/d0ob01826k.
9
Non-Functionalized Fullerenes and Endofullerenes in Aqueous Dispersions as Superoxide Scavengers.非功能化富勒烯和内包富勒烯在水基分散体中作为超氧阴离子清除剂。
Molecules. 2020 May 28;25(11):2506. doi: 10.3390/molecules25112506.
10
Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches.富勒烯衍生物作为肺癌细胞抑制剂的研究:使用 QSAR 方法探讨潜在描述符。
Int J Nanomedicine. 2020 Apr 14;15:2485-2499. doi: 10.2147/IJN.S243463. eCollection 2020.